Why INDP? Indaptus Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
INDP
$2.22+0.08 (+3.74%)
Market OpenUpdated 3:09 PM EDT
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products.